Log in to save to my catalogue

Discovery of a dual-action small molecule that improves neuropathological features of Alzheimer’s di...

Discovery of a dual-action small molecule that improves neuropathological features of Alzheimer’s di...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8784098

Discovery of a dual-action small molecule that improves neuropathological features of Alzheimer’s disease mice

About this item

Full title

Discovery of a dual-action small molecule that improves neuropathological features of Alzheimer’s disease mice

Publisher

United States: National Academy of Sciences

Journal title

Proceedings of the National Academy of Sciences - PNAS, 2022-01, Vol.119 (3), p.1-12

Language

English

Formats

Publication information

Publisher

United States: National Academy of Sciences

More information

Scope and Contents

Contents

Alzheimer’s disease (AD) is characterized by complex, multifactorial neuropathology, suggesting that small molecules targeting multiple neuropathological factors are likely required to successfully impact clinical progression. Acid sphingomyelinase (ASM) activation has been recognized as an important contributor to these neuropathological features...

Alternative Titles

Full title

Discovery of a dual-action small molecule that improves neuropathological features of Alzheimer’s disease mice

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8784098

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8784098

Other Identifiers

ISSN

0027-8424

E-ISSN

1091-6490

DOI

10.1073/pnas.2115082119

How to access this item